Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Clinical Utility
100%
Risk Stratification
100%
Prostate Cancer Patients
100%
ERG Protein Expression
100%
ERG Expression
100%
Androgen Deprivation Therapy
75%
Tumor
50%
Prostate Cancer
50%
Clinical Outcomes
50%
Gleason Score
50%
Lethal Infection
50%
PTEN Expression
50%
PTEN Loss
50%
PTEN Protein
50%
Multivariable
25%
Immunohistochemical Staining
25%
Patient Outcomes
25%
Protein Expression
25%
Tumor Samples
25%
Genetic Aberrations
25%
Protein Loss
25%
Intermediate Risk
25%
Prognostic Value
25%
Patient Subgroups
25%
Combined Marker
25%
Resistant Disease
25%
Castration-resistant
25%
Cancer-specific Survival
25%
Clinical Pathological Characteristics
25%
Prognostic Groups
25%
Double Immunofluorescence
25%
Prognostic Role
25%
Proportional Hazards Regression Analysis
25%
Medicine and Dentistry
Neoplasm
100%
Prostate Cancer
100%
Risk Stratification
100%
Protein Expression
100%
Androgen Deprivation Therapy
100%
Transcription Factor ERG
100%
Phosphatidylinositol 3,4,5 Trisphosphate 3 Phosphatase
100%
Diseases
100%
Gleason Score
66%
Proportional Hazards Model
33%
Immunohistochemistry
33%
Protein Depletion
33%
Cancer Specific Survival
33%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
100%
Prostate Cancer
100%
Androgen
100%
Phosphatidylinositol 3,4,5 Trisphosphate 3 Phosphatase
100%
Transcription Factor ERG
100%
Diseases
100%
Gleason Score
66%
Cancer Specific Survival
33%
Biochemistry, Genetics and Molecular Biology
Protein Expression
100%
Gleason Score
100%
Transcription Factor ERG
100%
Genetics
50%
Cancer Specific Survival
50%